We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
IntelliPharmaCeutics International Inc (QB) | USOTC:IPCIF | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.06 | 0.0379 | 0.12 | 1 | 21:00:05 |
|
|
Intellipharmaceutics International Inc.
(Registrant)
/s/ Andrew
Patient
|
Date: October 15, 2018
|
|
Andrew Patient
Chief Financial Officer
|
Exhibit
|
Description
|
||
99.1
|
Management Discussion And Analysis Of Financial Condition And
Results Of Operations for the Three and Nine Months Ended August
31, 2018
|
||
99.2
|
Condensed Unaudited Interim Consolidated Financial Statements and
Notes to Condensed Unaudited Interim Consolidated Financial
Statements of Intellipharmaceutics International Inc. for the Three
and Nine Months Ended August 31, 2018
|
||
99.3
|
News Release dated October 15, 2018 - Intellipharmaceutics
Announces Third Quarter 2018 Results
|
||
99.4
|
Form 52-109F2 - Chief Executive Officer
|
||
99.5
|
Form 52-109F2 - Chief Financial Officer
|
||
|
|
|
|
101.INS
|
|
XBRL
Instance Document
|
|
101.SCH
|
|
XBRL
Schema Document
|
|
101.CAL
|
|
XBRL
Calculation Linkbase Document
|
|
101.DEF
|
|
XBRL
Definition Linkbase Document
|
|
101.LAB
|
|
XBRL
Label Linkbase Document
|
|
101.PRE
|
|
XBRL
Presentation Linkbase Document
|
|
|
|
1 Year IntelliPharmaCeutics (QB) Chart |
1 Month IntelliPharmaCeutics (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions